Schedule 13G ownership disclosure
IONIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 462222100
Event date: 2022-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,350,460
- Percent of class
- 10.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-22-002321
- Form type
- SC 13G
- Filer
- IONIS PHARMACEUTICALS INC
- CIK
- CIK 874015
- Filed
- Apr 11, 2022
- Reporting period
- Mar 31, 2022
- Description
- Schedule 13G beneficial ownership